Outcomes Personal Pharmacist ™ Training Module/Encounter™ MTM Case Examples.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Texas Medicaid Asthma/COPD (Restrictive Airway Disease) Pilot program
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Medication Therapy Management: Methods to Increase Comprehensive Medication Review Participation Harrell T, RPh, Diaz M, PharmD Candidate, Ortega Y, PharmD.
The Value of Medication Therapy Management Services
Drug Utilization Review (DUR)
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Figures – Chapter 8. Figure 8.1 An input-output model of program testing.
Medication Therapy Management Jessica Sipe, PharmD Bartell Drugs Community Pharmacy Practice Resident March 1, 2011.
Medication Therapy Management Linda Mach, PharmD Bartell Drugs Community Practice Resident February 26, 2010.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
MaineCare & Opioid Treatment Where we are… How we got here… Where we are going… Kevin S. Flanigan, MD Medical Director Office of MaineCare Services.
TEXAS MEDICAID ASTHMA/COPD (RESTRICTIVE AIRWAY DISEASE) PILOT PROGRAM.
Polypharmacy Among Older Adults in Tehran Tehran University of Medical Sciences, School of Public Health, Islamic Republic of Iran Ahmadi, Batoul, Pharm.
March 2015 is. PHARMACISTS: TRUSTED CARE WHEN AND WHERE YOU NEED IT.
IHS Pharmacy Policies and Procedures
Medication Management – Tapping the Pharmacist’s Expertise for Employees with Multiple Medications Rosemarie Patodia, BScPhm, CGP Pharmacist, Manager,
Why are we learning this? How scientific knowledge (pharmacology, therapeutics) and clinical skills (measuring blood pressure, glucoses, drug information)
Following Your Treatment Plan. Taking your medication is an important part of your treatment. 2.
Social Pharmacy Lecture no. 8 Rational prescribing guidelines.
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Introducing the Medication Recording System Schedule Ed Castagna Mom & Pop’s Small Business Services.
Dispensing to in and out patients or Drug distribution system
In Which Areas Have Clinical Pharmacists Been the Most Successful in Patient Care ? Hospital inpatient unit (wards) –Therapeutic drug monitoring –Anticoagulation.
The Value of Medication Therapy Management Services.
State of New Hampshire Pharmacy Benefit Changes Effective November 1, 2011 Presented By: Melisa Briggs.
Florida Agency for Health Care Administration Florida Center for Health Information and Policy Analysis Florida Public Health Association - Medical Director’s.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
FINANCIAL ISSUES CHAPTER 14. CHAPTER OUTLINE Financial Issues Third-Party Programs – private health insurance – managed care programs – public health.
Documentation of Care Provided Patient’s care - who should do it? WHY DOCUMENT? When should it occur? Where should it be documented? How should it be documented?
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
What do we know? Idara C. Eshiet. Competency 1. How do you determine if a patient is competent when presented with a case? 2. If a patient is said to.
Transitions of Care: Using Pharmacists as Part of Team Based Care Care Transformation Collaborative of R.I. TARA HIGGINS, PHARMD, CDOE, CVDOE CLINICAL.
Prilosec1 ® 20 mg Tablets Rx to OTC Switch Daiva Shetty, M.D. Division of Over-the-Counter Drug Products (HFD-560) Food and Drug Administration 1.
Humana’s Medication Therapy Management Program Robert McMahan, PharmD, MBA Humana Inc. Third National Medicare Conference October 17, 2006.
A FORMATIVE STUDY TO DESIGN AN INTERVENTION INVOLVING MOTHERS, DRUGS VENDORS AND HEALTH WORKERS IN A SELF-PROCESS OF BEHAVIORAL CHANGE FOR RATIONAL DRUG.
Antibiotic Myths and Facts MYTH: Antibiotics help reduce the length and severity of a cold or flu FACT: Antibiotics have no effect on colds or flu. The.
Pharmacists Working In Primary Healthcare Centers: Are They Ready To Expand Their Role? Sinaa Alageel, MSc, PhD; Norah Abanmy MSc Department of Clinical.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
MTM Medication Therapy Management. What is Medication Therapy Management? From 1996 to 2006, the number of prescription medications dispensed increased.
Medication Therapy Management Part D Programs Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2014.
Polypharmacy in a Patient Centered Medical Home Carilion Clinic – VTC Family Medicine Roanoke, Virginia.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Documentation in Practice Dept. of Clinical Pharmacy.
Other Environments Chapter 17. Mail Order Pharmacy Mail order pharmacy is the fastest growing segment of pharmacy. Mail order pharmacy is used for maintenance.
Communicating with Patients and Providers HIV Care and ART: A Course for Pharmacists.
Drug Utilization Review & Drug Utilization Evaluation: An Overview
Denis G. Patterson, DO Nevada Advanced Pain Specialists Contact Information.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
Medication therapy management
Medication Therapy Management (MTM)
Antibiotics: handle with care!
Documentation of pharmaceutical care
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
Survey of Minor Ailment Sufferers
Pharmaceutical Care Plan
Using Medicines Safely (2:50)
Clinical Pharmacy II.
Medication order entry & Fill process
Communication Skills Lecture 1-2
Hospital Antibiotic Stewardship Programs
Pharmacy practice experience I
Chapter 9: Community Pharmacy
Pharmacy practice experience I
Using Medicines Safely (2:50)
BSc. Pharmacy, MSc. Clinical Pharmacy, PhD. Student
CASE STUDIES.
Presentation transcript:

Outcomes Personal Pharmacist ™ Training Module/Encounter™ MTM Case Examples

Case Example #1  A 45 year old female, presented to a pharmacy with a prescription for a sulfa antibiotic (Drug A).  The pharmacist reviewed her drug history and found a notation that she is allergic to sulfas. The previous reaction was anaphylaxis. The pharmacist contacted the physician recommending a switch to an alternative medication (Drug B). The physician was not aware of the patient’s history and agreed with the pharmacist’s recommendation.  The pharmacist filled the new prescription for the alternative medication and properly educated the patient. Upon follow-up the pharmacist learned that the patient’s infection had resolved after a full course of therapy.

Case Example #1: Question 1  How many Encounter claims should be filed as a result of Case Example #1?  One  Two  Three  Four

Case Example #1: Question 2  What is the Reason for the first claim?  Needs Therapy  Suboptimal Drug Selection  Adverse Drug Reaction  Other

Case Example #1: Question 3  What is the Action for the first claim?  Comprehensive Medication Review (CMR)  Prescriber Consultation  Patient Education/Monitoring  Patient Compliance Consultation

Case Example #1: Question 4  What is the Result for the first claim?  Therapeutic Success  Initiated New Therapy  Changed Drug  Altered Regimen/Changed Drug

Case Example #1: Question 5  What is the initial prescription information for the first claim?  The sulfa the patient took previously which caused an anaphylactic reaction  The alternate antibiotic (Drug B) recommended by the pharmacist  The antibiotic (Drug A) originally prescribed by the doctor  There is no initial prescription information

Case Example #1: Question 6  What is the final prescription information for the first claim?  The sulfa the patient took previously which caused an anaphylactic reaction  The antibiotic (Drug B) recommended by the pharmacist  The antibiotic (Drug A) originally prescribed by the doctor  There is no final prescription information

Case Example #1: Question 7  What is the frequency of therapy for the first claim?  Acute  Intermittent  Chronic  You do not need to select a frequency of therapy

Case Example #1: Question 8  What is the ECA for the first claim?  Level 1: Improved Quality of Care  Level 3: Additional Prescription Order  See Previous Claim  Level 7: Life Threatening

Case Example #1: Question 9  What should be included in the note of the first claim?  Description of the education and monitoring  Description of the intervention  Justification for the ECA selected  B & C

Case Example #1: Question 10  What is the Reason for the second claim?  New/Changed Prescription Therapy  Suboptimal Drug Selection  Adverse Drug Reaction  Other

Case Example #1: Question 11  What is the Action for the second claim?  Comprehensive Medication Review (CMR)  Prescriber Consultation  Patient Education/Monitoring  Patient Compliance Consultation

Case Example #1: Question 12  What is the Result for the second claim?  Therapeutic Success  Initiated New Therapy  Changed Drug  Altered Regimen/Changed Drug

Case Example #1: Question 13  What is the initial prescription information for the second claim?  The sulfa the patient took previously which caused an anaphylactic reaction  The alternate antibiotic (Drug B) recommended by the pharmacist  The antibiotic (Drug A) originally prescribed by the doctor  There is no initial prescription information

Case Example #1: Question 14  What is the final prescription information for the second claim?  The sulfa the patient took previously which caused an anaphylactic reaction  The antibiotic (Drug B) recommended by the pharmacist  The antibiotic (Drug A) originally prescribed by the doctor  There is no final prescription information

Case Example #1: Question 15  What is the frequency of therapy for the second claim?  Acute  Intermittent  Chronic  You do not need to select a frequency of therapy

Case Example #1: Question 16  What is the ECA for the second claim?  Level 1: Improved Quality of Care  Level 3: Additional Prescription Order  Level 5: Emergency Room Visit  Level 7: Life Threatening

Case Example #1: Question 17  What should be included in the note of the second claim?  Description of the education and monitoring  Description of the intervention  Justification for the ECA selected  B & C

Case Example #2  A 54 year old male presented to a pharmacy requesting a refill of his medication (Drug A) to prevent gout attacks. He stated that he was having an acute gout flare and he did not feel the medication was helping.  The pharmacist educated the patient that this medication is used for maintenance therapy to prevent gout attacks and explained that the physician must be contacted to recommend a treatment (Drug B) for the current attack. The pharmacist contacted the doctor and recommended a treatment. The physician approved the new order.  The pharmacist educated the patient about the new medication and how to start the refill when the gout flare resolves. A monitoring call was scheduled for two days later. During the monitoring call the patient stated that his attack has resolved and he was doing much better with no questions, and was now taking the medication daily for maintenance.

Case Example #2: Question 1  How many Encounter claims should be filed as a result of Case Example #2?  One  Two  Three  Four

Case Example #2: Question 2  What is the Reason for the first claim?  Other  Overuse  Underuse  Administration/Technique

Case Example #2: Question 3  What is the Action for the first claim?  Patient Education/Monitoring  Prescriber Consultation  Patient Consultation  Patient Compliance Consultation

Case Example #2: Question 4  What is the Result for the first claim?  Therapeutic Success  Altered Compliance  Initiated New Therapy  Altered Regimen/Changed Drug

Case Example #2: Question 5  What is the initial prescription information for the first claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no initial prescription information

Case Example #2: Question 6  What is the final prescription information for the first claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no final prescription information

Case Example #2: Question 7  What is the frequency of therapy for the first claim?  Acute  Intermittent  Chronic  You do not need to select a frequency of therapy

Case Example #2: Question 8  What is the ECA for the first claim?  Level 1: Improved Quality of Care  Level 2: Drug Product Costs  Level 3: Additional Physician Visit  Level 5: Emergency Room Visit

Case Example #2: Question 9  What should be included in the note of the first claim?  Description of the education and monitoring  Description of the intervention  Justification for the ECA selected  B & C

Case Example #2: Question 10  What is the Reason for the second claim?  New/Changed Prescription Therapy  OTC Therapy  Needs Therapy  Unnecessary Therapy

Case Example #2: Question 11  What is the Action for the second claim?  Comprehensive Medication Review (CMR)  Prescriber Consultation  Patient Education/Monitoring  Patient Compliance Consultation

Case Example #2: Question 12  What is the Result for the second claim?  Therapeutic Success  Initiated New Therapy  Changed Drug  Altered Regimen/Changed Drug

Case Example #2: Question 13  What is the initial prescription information for the second claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no initial prescription information

Case Example #2: Question 14  What is the final prescription information for the second claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no final prescription information

Case Example #2: Question 15  What is the frequency of therapy for the second claim?  Acute  Intermittent  Chronic  You do not need to select a frequency of therapy

Case Example #2: Question 16  What is the ECA for the second claim?  Level 1: Improved Quality of Care  Level 3: Additional Physician Visit  Level 5: Emergency Room Visit  See Previous Claim

Case Example #2: Question 17  What should be included in the note of the second claim?  Description of the education and monitoring  Description of the intervention  Justification for the ECA selected  B & C

Case Example #2: Question 18  What is the Reason for the third claim?  New/Changed Prescription Therapy  Suboptimal Drug Selection  Adverse Drug Reaction  Other

Case Example #2: Question 19  What is the Action for the third claim? A.Comprehensive Medication Review (CMR)  Prescriber Consultation  Patient Education & Monitoring  Patient Compliance Consultation

Case Example #2: Question 20  What is the Result for the third claim?  Therapeutic Success  Initiated New Therapy  Changed Drug  Altered Regimen/Changed Drug

Case Example #2: Question 21  What is the initial prescription information for the third claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no initial prescription information

Case Example #2: Question 22  What is the final prescription information for the third claim?  The medication to prevent gout attacks (Drug A)  The medication to treat gout attacks (Drug B)  A pain medication  There is no final prescription information

Case Example #2: Question 23  What is the frequency of therapy for the third claim?  Acute  Intermittent  Chronic  You do not need to select a frequency of therapy

Case Example #2: Question 24  What is the ECA for the third claim?  Level 1: Improved Quality of Care  Level 3: Additional Prescription Order  Level 5: Emergency Room Visit  Level 7: Life Threatening

Case Example #2: Question 25  What should be included in the note of the third claim?  Description of the education and monitoring  Description of the intervention  Justification for the ECA selected  B & C

46 Congratulations! This concludes Module/Encounter MTM Case Examples.